Candriam S.C.A. Has $15.38 Million Position in Healthcare Realty Trust Incorporated $HR

Candriam S.C.A. cut its stake in shares of Healthcare Realty Trust Incorporated (NYSE:HR) by 37.2% in the second quarter, Holdings Channel reports. The fund owned 969,447 shares of the real estate investment trust’s stock after selling 573,993 shares during the period. Candriam S.C.A.’s holdings in Healthcare Realty Trust were worth $15,376,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Massachusetts Financial Services Co. MA bought a new stake in Healthcare Realty Trust during the first quarter worth about $100,817,000. Charles Schwab Investment Management Inc. boosted its holdings in shares of Healthcare Realty Trust by 2.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 5,470,199 shares of the real estate investment trust’s stock worth $92,446,000 after acquiring an additional 139,019 shares in the last quarter. Northern Trust Corp grew its position in Healthcare Realty Trust by 1.0% during the 1st quarter. Northern Trust Corp now owns 4,080,435 shares of the real estate investment trust’s stock worth $68,959,000 after acquiring an additional 39,466 shares during the last quarter. Russell Investments Group Ltd. increased its holdings in Healthcare Realty Trust by 2.5% during the 1st quarter. Russell Investments Group Ltd. now owns 2,841,636 shares of the real estate investment trust’s stock valued at $48,023,000 after purchasing an additional 69,114 shares in the last quarter. Finally, William Blair Investment Management LLC increased its holdings in Healthcare Realty Trust by 0.6% during the 2nd quarter. William Blair Investment Management LLC now owns 2,278,809 shares of the real estate investment trust’s stock valued at $36,142,000 after purchasing an additional 14,015 shares in the last quarter.

Healthcare Realty Trust Price Performance

Shares of NYSE HR opened at $18.06 on Friday. Healthcare Realty Trust Incorporated has a fifty-two week low of $14.09 and a fifty-two week high of $18.97. The firm has a market capitalization of $6.35 billion, a P/E ratio of -15.70 and a beta of 0.95. The company’s 50 day simple moving average is $18.10 and its 200 day simple moving average is $16.55.

Healthcare Realty Trust (NYSE:HR) last issued its earnings results on Thursday, October 30th. The real estate investment trust reported $0.41 EPS for the quarter, beating the consensus estimate of $0.40 by $0.01. The company had revenue of $297.77 million during the quarter, compared to analysts’ expectations of $291.10 million. Healthcare Realty Trust had a negative net margin of 32.95% and a negative return on equity of 7.70%. The business’s revenue for the quarter was down 6.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.39 EPS. Healthcare Realty Trust has set its FY 2025 guidance at 1.590-1.60 EPS. Sell-side analysts expect that Healthcare Realty Trust Incorporated will post 1.59 EPS for the current fiscal year.

Healthcare Realty Trust Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 21st. Investors of record on Tuesday, November 11th will be issued a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 5.3%. The ex-dividend date is Monday, November 10th. Healthcare Realty Trust’s dividend payout ratio is currently -90.57%.

Wall Street Analyst Weigh In

HR has been the topic of a number of recent analyst reports. Royal Bank Of Canada assumed coverage on Healthcare Realty Trust in a report on Wednesday, October 8th. They set a “sector perform” rating and a $19.00 target price on the stock. Cantor Fitzgerald assumed coverage on shares of Healthcare Realty Trust in a research report on Wednesday, October 1st. They set an “overweight” rating and a $23.00 price target on the stock. Wells Fargo & Company raised shares of Healthcare Realty Trust from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $16.00 to $18.00 in a report on Monday, October 20th. Raymond James Financial downgraded shares of Healthcare Realty Trust from a “market perform” rating to an “underperform” rating in a research note on Monday, September 15th. Finally, Wall Street Zen upgraded shares of Healthcare Realty Trust from a “sell” rating to a “hold” rating in a research report on Saturday, November 8th. Three analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Healthcare Realty Trust has an average rating of “Hold” and a consensus target price of $18.78.

Insiders Place Their Bets

In other Healthcare Realty Trust news, EVP Julie F. Wilson sold 15,000 shares of the stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $18.00, for a total value of $270,000.00. Following the transaction, the executive vice president owned 113,419 shares of the company’s stock, valued at approximately $2,041,542. This represents a 11.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.37% of the company’s stock.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.